GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (FRA:NNFN) » Definitions » Ending Cash Position

MannKind (FRA:NNFN) Ending Cash Position : €177.8 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is MannKind Ending Cash Position?

MannKind's Ending Cash Position for the quarter that ended in Mar. 2024 was €177.8 Mil.

MannKind's quarterly Ending Cash Position increased from Sep. 2023 (€77.8 Mil) to Dec. 2023 (€218.7 Mil) but then declined from Dec. 2023 (€218.7 Mil) to Mar. 2024 (€177.8 Mil).

MannKind's annual Ending Cash Position declined from Dec. 2021 (€109.9 Mil) to Dec. 2022 (€65.9 Mil) but then increased from Dec. 2022 (€65.9 Mil) to Dec. 2023 (€218.7 Mil).


MannKind Ending Cash Position Historical Data

The historical data trend for MannKind's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Ending Cash Position Chart

MannKind Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.20 55.21 109.90 65.86 218.69

MannKind Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.20 79.55 77.79 218.69 177.81

MannKind Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MannKind's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=63.976+154.71
=218.7

MannKind's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=219.401+-41.591
=177.8


MannKind Ending Cash Position Related Terms

Thank you for viewing the detailed overview of MannKind's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind (FRA:NNFN) Business Description

Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind (FRA:NNFN) Headlines

No Headlines